Similar articles

• Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism.

  Hawke L, Bowman ML, Poon MC, Scully MF, Rivard GE, James PD. Hawke L, et al. Blood. 2016 Jul 28;128(4):584-93. doi: 10.1182/blood-2015-10-678052. Epub 2016 Jun 17. Blood. 2016. PMID: 27317792 Free PMC article. Clinical Trial.
• Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.

  Yadegari H, Driesen J, Pavlova A, Biswas A, Hertfelder HJ, Oldenburg J. Yadegari H, et al. Thromb Haemost. 2012 Oct;108(4):662-71. doi: 10.1160/TH12-02-0089. Epub 2012 Aug 7. Thromb Haemost. 2012. PMID: 22871923
• Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.

  Gadisseur A, Berneman Z, Schroyens W, Michiels JJ. Gadisseur A, et al. Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8. Acta Haematol. 2009. PMID: 19506359 Review.
• Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.

  Ginsburg D, Konkle BA, Gill JC, Montgomery RR, Bockenstedt PL, Johnson TA, Yang AY. Ginsburg D, et al. Proc Natl Acad Sci U S A. 1989 May;86(10):3723-7. doi: 10.1073/pnas.86.10.3723. Proc Natl Acad Sci U S A. 1989. PMID: 2786201 Free PMC article.
• The molecular basis of von Willebrand disease.

  Mohlke KL, Nichols WC, Ginsburg D. Mohlke KL, et al. Int J Clin Lab Res. 1999;29(1):1-7. doi: 10.1007/s005990050054. Int J Clin Lab Res. 1999. PMID: 10356656 Review.